A settlement may be in the works between Mosaid Technologies Inc. and Infineon Technologies AG for a patent infringement case in Texas. Ottowa-based Mosaid said that the Texas court is granting a 30-day delay of the previously scheduled hearing to allow parties to “focus on ongoing settlement discussions.”
As Capitol Hill gave patent reform another nod this week, industry representatives pushed lawmakers to help curb excess patent legislation by crafting a beefed-up process for disputing granted patents at the U.S. Patent and Trademark Office.
JetBlue Airways Corp. has been sued by a small patent-holding company in the Cayman Islands, making the carrier the latest in a long line of companies to be targeted by an inventor of document-scanning technology.
After years of legal wrangling, New York powerhouse Weil, Gotshal & Manges LLP has decided to throw in the towel and settle a long-running malpractice suit related to the firm’s representation of a retail store in an unfair competition suit against Italian fashion company Fendi.
In a move that underscores growing concerns among shareholders and regulators about stock-option grants, five pension funds filed a lawsuit Thursday against UnitedHealthGroup Inc. and 17 of the company’s employees, claiming that executives unjustly profited from and harmed the company by backdating stock options.
In the latest move in a four-month long patent feud, Sicor Pharmaceuticals Inc., a unit of Teva Pharmaceuticals, is taking aim at Eli Lilly & Co. in federal court, seeking declaratory judgment that two of Sicor’s patents covering its Gemzar chemotherapy treatment are invalid and will not be infringed by Sicor’s generic version of the product.
Shire Laboratories Inc. has filed a patent infringement lawsuit against generic drug maker Corepharma LLC, accusing the company of infringing patents for its lucrative, number-three drug Carbatrol, a treatment for seizure disorders.
J.H. Cohn LLP may not be as huge a restructuring outfit as some, but for the past two and a half decades, the firm has relished its role as a key niche player in the turnaround market.
A Detroit-based pension fund for firemen and police officers has hauled Bausch & Lomb Inc. into a Manhattan federal court, accusing the company of misleading investors and failing to disclose health risks associated with its contact lens products.
Gilbert Heintz & Randolph LLP is once again fighting back to recover some of the nearly $13 million in fees that were voided last month by the bankruptcy judge for Congoleum Corp., which had accused the law firm of conflict of interest.
A federal court has dismissed a consolidated shareholder lawsuit that accused officers and directors of pharmaceutical firm Merck & Co. Inc. of breaching their duties by covering up health risks of the recalled painkiller Vioxx.
Drug maker Cephalon Inc.’s attempts to stave off generic competition for its narcolepsy drug Provigil has landed it in the middle of a class action antitrust lawsuit, along with six of its competitors.
Broadening a nine-month long investigation into an insider-trading scandal involving employees of investment banks Merrill Lynch & Co. Inc. and Goldman Sachs Group Inc., federal prosecutors have nabbed a postal worker for tipping two former investment bankers about a grand jury’s accounting fraud probe of Bristol-Meyers Squibb Co.
In a long-simmering patent dispute over blockbuster osteoporosis drug Fosamax, Merck & Co. is striking back at Israeli generic maker Teva Pharmaceuticals, saying Teva garnered a Federal Circuit victory last year by withholding one of its own patent applications in a move Merck is calling a “grave miscarriage of justice.”
Amid plans to merge with French telecommunications equipment company Alcatel SA, Lucent Technologies said in a filing with the U.S. Securities and Exchange Commission this week that it is facing a class action lawsuit brought by shareholders opposing the deal.
A subsidiary of patent-holding company Acacia Research Corp. filed a lawsuit against several major insurance companies this week, accusing the companies of infringing its patent for multi-dimensional barcode technology.
At barely two-years-old, restructuring firm Capstone Advisory Group LLC may be the proverbial new kid on the block, but don’t be fooled—the Capstone crew has been in this business a long time, according to the firm’s top executives.
Integrated circuitry maker Conexant Systems Inc. will pay Texas Instruments Inc. $70 million to settle a two-year-old patent infringement battle that included allegations of widespread antitrust violations.
As the demand for IP counseling continues to grow, boutique IP law firm Lerner David Littenberg, Krumholz & Mentlik LLP has beefed up its roster by adding former Federal Judge Alfred “Jim” Lechner, Jr.
The patents for popular anti-anxiety drug Niravam have sparked a court battle between patent holder Schwarz Pharma and generics maker Par Pharmaceuticals.